UNIVERSITY OF YAMANASHI
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- -
- Established
- 1949-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.yamanashi.ac.jp/
Clinical Trials
5
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:2
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (50.0%)Phase 2
2 (50.0%)sCLEC-2 in Stroke Study
Not yet recruiting
- Conditions
- Acute Ischemic StrokeTransient Ischemic Attack
- First Posted Date
- 2022-10-13
- Last Posted Date
- 2022-10-13
- Lead Sponsor
- University of Yamanashi
- Target Recruit Count
- 600
- Registration Number
- NCT05579405
- Locations
- 🇯🇵
LSI Medience Co., Katori, Chiba, Japan
🇯🇵Kyushu Medical Center, Fukuoka-shi, Fukuoka, Japan
🇯🇵Iwate Medical University, Shiwa-gun, Iwate, Japan
Peptide Vaccination in Treating Patients With Esophageal Cancer (STF-II)
Phase 2
- Conditions
- Esophageal Cancer
- First Posted Date
- 2010-12-28
- Last Posted Date
- 2010-12-28
- Lead Sponsor
- University of Yamanashi
- Target Recruit Count
- 60
- Registration Number
- NCT01267578
- Locations
- 🇯🇵
University of Yamanashi, First Department of Surgery, Chuo, Yamanashi, Japan
Study of Chemo-Immunotherapy in Head and Neck Cancer Patients
Phase 1
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2010-06-24
- Last Posted Date
- 2011-08-24
- Lead Sponsor
- University of Yamanashi
- Target Recruit Count
- 10
- Registration Number
- NCT01149902
- Locations
- 🇯🇵
Umiversity of Yamanashi Hospital, Chuo, Yamanashi, Japan
A Study With Peptide Vaccination in Treating Patients With Esophageal Cancer
Phase 2
- Conditions
- Esophageal Cancer
- First Posted Date
- 2009-10-15
- Last Posted Date
- 2009-10-15
- Lead Sponsor
- University of Yamanashi
- Target Recruit Count
- 60
- Registration Number
- NCT00995358
- Locations
- 🇯🇵
First Department of Surgery, University of Yamanashi, Chuo, Yamanashi, Japan
Peptide Vaccination in Treating Patients With Esophageal Cancer
Phase 1
- Conditions
- Esophageal Cancer
- First Posted Date
- 2008-05-22
- Last Posted Date
- 2008-05-29
- Lead Sponsor
- University of Yamanashi
- Target Recruit Count
- 10
- Registration Number
- NCT00682227
- Locations
- 🇯🇵
University of Yamanashi, First Department of Surgery, 1110 Shimokato, Chuo-city, Yamanashi, Japan
News
No news found